Insider trades

Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.

Open-market buys: 923 trades; $2B in total
Open-market sales: 1,038 trades; $2.3B in total
Insiders filing: 464 insiders; Last 7 days
Companies with several buyers: 26; Last 7 days

Pasithea Therapeutics KTTA

		Trade type
Coastlands Capital10% Owner	Pasithea TherapeuticsKTTA	Open-market buy	06/17	06/22	100,000 sh	$0.53	$53,000	+2.7%
Lawrence SteinmanDirector	Pasithea TherapeuticsKTTA	Open-market buy	25/11/28	25/12/01	133,333 sh	$0.75	$99,999.75	+200.9%
Tiago MarquesCEO	Pasithea TherapeuticsKTTA	Open-market buy	25/11/28	25/12/01	33,333 sh	$0.75	$24,999.75	+83.3%
Simon DumesnilDirector	Pasithea TherapeuticsKTTA	Open-market buy	25/11/28	25/12/01	33,333 sh	$0.75	$24,999.75	+1333.3%
Tiago MarquesCEO	Pasithea TherapeuticsKTTA	Open-market sale	25/05/12	25/05/14	960 sh	$0.83	$796.8	−2.3%
Lawrence SteinmanDirector	Pasithea TherapeuticsKTTA	Open-market buy	23/06/02	23/06/06	30,000 sh	$0.43	$12,900	+2.3%